Tag: Sexually Transmitted Diseases: AIDS/HIV
Antiretroviral Prescribing in Pregnancy Strays From National Guidelines
Many prescribed ARVs with insufficient evidence, not recommended for use in pregnant women with HIV
Facebook Asked to Remove ‘Factually Inaccurate’ Ads About PrEP
Ads are from law firms seeking litigants for class-action lawsuit against Truvada maker Gilead Sciences
Cost Saving-Related Rx Nonadherence Found for 7 Percent With HIV
Persons nonadherent due to cost more likely to have visited ED, been hospitalized, not be virally suppressed
New HIV Infections Remained Stable in U.S. From 2013 to 2017
Of the 1.2 million people with indications for PrEP in 2018, only 18.1 percent had been prescribed PrEP
New Federal Program Provides Free HIV Prevention Drugs to Uninsured
Expanding access to PrEP is key part of government's aim of ending nation's HIV epidemic by 2030
November 2019 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for November 2019. This roundup includes...
Maternal Efavirenz May Up Risk for Microcephaly Among Offspring
Maternal efavirenz use tied to increased risk among children who are HIV-exposed but uninfected
Distribution of Self-Test Kits Can Up HIV Awareness
Testing increased for men who have sex with men who received self-testing kits and their social network members
Syringe Exchange Program Has Positive Impact on HIV Diagnoses
Estimated 10,592 HIV diagnoses averted in Philadelphia, 1,891 diagnoses in Baltimore over 10 years
Menopause Occurs at Median Age of 48 in Canadian Women With HIV
Lower education, hepatitis C coinfection independently linked to menopause at <45 years
